$PTGX Protagonist Therapeutics, Inc Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Protagonist Therapeutics, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Protagonist Therapeutics, Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in Protagonist Therapeutics, Inc for free.
IRS Number: 980505495
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PTGX
Company Address: 7707 GATEWAY BLVD., SUITE 140 NEWARK 94560-1160
Phone number: 408-649-7370
Former name: Protagonist Inc, date of change: 2006-10-02
Former name: Protagonist Therapeutics Inc, date of change: 2013-06-05
Market Capitalization: $282.80M
Prev close: $17.90
Average Daily Volume: 39,371
Days Low: $16.60
Year Low: $10.02
Year High: $26.36
Protagonist Therapeutics, Inc Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | PTGX | Protagonist Therap ... | Williams Lewis T | Director | Option Exercise | A | 35.23 | 18,000 | 634,140 | 18,000 | |
| May 28 2021 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 35.23 | 18,000 | 634,140 | 18,000 | |
| May 28 2021 | PTGX | Protagonist Therap ... | O'Dowd Sarah A | Director | Option Exercise | A | 35.23 | 18,000 | 634,140 | 18,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Option Exercise | A | 23.57 | 90,000 | 2,121,300 | 90,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Grant | A | 0.00 | 12,000 | 0 | 14,000 | 2 K to 14 K (+600.00 %) |
| Feb 26 2021 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | A | 23.57 | 225,000 | 5,303,250 | 225,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Grant | A | 0.00 | 25,000 | 0 | 451,144 | 426.1 K to 451.1 K (+5.87 %) |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 23.57 | 65,000 | 1,532,050 | 65,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 10,000 | 0 | 62,427 | 52.4 K to 62.4 K (+19.07 %) |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Kalkofen Donald A. | Chief Financial Off ... | Option Exercise | A | 23.57 | 55,000 | 1,296,350 | 55,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Kalkofen Donald A. | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 10,386 | 2.9 K to 10.4 K (+259.88 %) |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Gupta Suneel | Chief Development O ... | Option Exercise | A | 23.57 | 80,000 | 1,885,600 | 80,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Gupta Suneel | Chief Development O ... | Grant | A | 0.00 | 12,000 | 0 | 63,987 | 52 K to 64 K (+23.08 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | M | 6.98 | 3,700 | 25,826 | 3,600 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | M | 6.98 | 4,700 | 32,806 | 7,300 |
View all Protagonist Therapeutics, Inc insider transactions.